Missouri is positioned to launch a statewide prescription drug monitoring program at last, but clinical professionals will not have access to patient-specific data to potentially prevent or treat addiction disorders.
Tom Insel, the former NIMH director and current director of clinical neuroscience at Alphabet Inc.’s Verily Life Services, says a technology revolution could change the landscape of behavioral healthcare.
Data from the Blue Cross Blue Shield Health Index, a new measurement tool, identifies health conditions with the greatest impact on communities. Analysis of the data draws a correlation between community health and economic strength.
Value-based payment models are becoming more common, but the IT vendors surveyed by Behavioral Healthcare Executive aren’t sure that providers are prepared for the shift from fee-for-service. DOWNLOAD THE FULL SURVEY RESULTS.